The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2

Genetic disorders of lymphocyte cytotoxicity predispose patients to hemophagocytic lymphohistiocytosis (HLH). Reduced lymphocyte cytotoxicity has been demonstrated in Hermansky-Pudlak syndrome type 2 (HPS2), but only a single patient was reported who developed HLH. Because that patient also carried...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Jessen, Birthe, Bode, Sebastian F. N., Ammann, Sandra, Chakravorty, Subarna, Davies, Graham, Diestelhorst, Jana, Frei-Jones, Melissa, Gahl, William A., Gochuico, Bernadette R., Griese, Matthias, Griffiths, Gillian, Janka, Gritta, Klein, Christoph, Kögl, Tamara, Kurnik, Karin, Lehmberg, Kai, Maul-Pavicic, Andrea, Mumford, Andrew D., Pace, David, Parvaneh, Nima, Rezaei, Nima, de Saint Basile, Geneviève, Schmitt-Graeff, Annette, Schwarz, Klaus, Karasu, Gulsun T., Zieger, Barbara, zur Stadt, Udo, Aichele, Peter, Ehl, Stephan
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2013
Soggetti:
Immunobiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3624940/
https://ncbi.nlm.nih.gov/pubmed/23403622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-463166
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi